{"count": 14, "results": [{"_id": "32782332", "pmid": 32782332, "pmcid": "PMC7419289", "title": "Metformin reduces saturated fatty acid-induced lipid accumulation and inflammatory response by restoration of autophagic flux in endothelial cells", "journal": "Sci Rep", "authors": ["Kim HS", "Ren G", "Kim T", "Bhatnagar S", "Yang Q", "Bahk YY", "Kim JA"], "date": "2020-08-11T00:00:00Z", "doi": "10.1038/s41598-020-70347-w", "meta_date_publication": "2020 Aug 11", "meta_volume": "10", "meta_issue": "1", "meta_pages": "13523", "score": 50252.97, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduces @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@LD@@@ by enhancing the degradation of @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@LD@@@, but not by inhibiting the formation of @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@LD@@@", "citations": {"NLM": "Kim HS, Ren G, Kim T, Bhatnagar S, Yang Q, Bahk YY, Kim JA. Metformin reduces saturated fatty acid-induced lipid accumulation and inflammatory response by restoration of autophagic flux in endothelial cells Sci Rep. 2020 Aug 11;10(1):13523. PMID: 32782332", "BibTeX": "@article{32782332, title={Metformin reduces saturated fatty acid-induced lipid accumulation and inflammatory response by restoration of autophagic flux in endothelial cells}, author={Kim HS and Ren G and Kim T and Bhatnagar S and Yang Q and Bahk YY and Kim JA}, journal={Sci Rep}, volume={10}, number={1}, pages={13523}}"}}, {"_id": "40520024", "pmid": 40520024, "title": "Metformin Alleviates Liver Metabolic Dysfunction in Polycystic Ovary Syndrome by Activating the Ethe1/Keap1/PINK1 Pathway.", "journal": "Int J Biol Sci", "authors": ["Xie Y", "Tian Y", "Huang J", "Deng W", "Li X", "Liu Y", "Liu H", "Gao L", "Xie Q", "Yu Q"], "date": "2025-05-21T00:00:00Z", "doi": "10.7150/ijbs.104778", "meta_date_publication": "2025", "meta_volume": "21", "meta_issue": "8", "meta_pages": "3505-3526", "score": 50243.453, "text_hl": "Results: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ effectively alleviated @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@hepatic lipid accumulation@@@ in the @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Xie Y, Tian Y, Huang J, Deng W, Li X, Liu Y, Liu H, Gao L, Xie Q, Yu Q. Metformin Alleviates Liver Metabolic Dysfunction in Polycystic Ovary Syndrome by Activating the Ethe1/Keap1/PINK1 Pathway. Int J Biol Sci. 2025;21(8):3505-3526. PMID: 40520024", "BibTeX": "@article{40520024, title={Metformin Alleviates Liver Metabolic Dysfunction in Polycystic Ovary Syndrome by Activating the Ethe1/Keap1/PINK1 Pathway.}, author={Xie Y and Tian Y and Huang J and Deng W and Li X and Liu Y and Liu H and Gao L and Xie Q and Yu Q}, journal={Int J Biol Sci}, volume={21}, number={8}, pages={3505-3526}}"}}, {"_id": "34689672", "pmid": 34689672, "title": "Progenies of gestational diabetes mellitus exhibit sex disparity in metabolism after respective therapies of insulin, glibenclamide, and metformin in dams during pregnancy.", "journal": "Arch Physiol Biochem", "authors": ["Lu Y", "Jia Y", "Lu J", "Liu J", "Xu Y", "Liu Y", "Chen K"], "date": "2021-10-23T00:00:00Z", "doi": "10.1080/13813455.2021.1991957", "meta_date_publication": "2021 Oct 23", "meta_volume": "", "meta_issue": "", "meta_pages": "1-13", "score": 50242.75, "text_hl": "RESULTS: The dyslipidaemia, @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@hepatic lipid abnormality@@@, and @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin insensitivity@@@ caused by @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@GDM@@@ were persistently normalised in male adult offspring by the respective therapies of insulin, @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ during maternal pregnancy. ", "citations": {"NLM": "Lu Y, Jia Y, Lu J, Liu J, Xu Y, Liu Y, Chen K. Progenies of gestational diabetes mellitus exhibit sex disparity in metabolism after respective therapies of insulin, glibenclamide, and metformin in dams during pregnancy. Arch Physiol Biochem. 2021 Oct 23;():1-13. PMID: 34689672", "BibTeX": "@article{34689672, title={Progenies of gestational diabetes mellitus exhibit sex disparity in metabolism after respective therapies of insulin, glibenclamide, and metformin in dams during pregnancy.}, author={Lu Y and Jia Y and Lu J and Liu J and Xu Y and Liu Y and Chen K}, journal={Arch Physiol Biochem}, pages={1-13}}"}}, {"_id": "32192650", "pmid": 32192650, "title": "Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.", "journal": "J Am Coll Cardiol", "authors": ["Marfella R", "Amarelli C", "Cacciatore F", "Balestrieri ML", "Mansueto G", "D'Onofrio N", "Esposito S", "Mattucci I", "Salerno G", "De Feo M", "D'Amico M", "Golino P", "Maiello C", "Paolisso G", "Napoli C"], "date": "2020-03-24T00:00:00Z", "doi": "10.1016/j.jacc.2020.01.018", "meta_date_publication": "2020 Mar 24", "meta_volume": "75", "meta_issue": "11", "meta_pages": "1249-1262", "score": 50240.75, "text_hl": "We evaluated cardiomyocyte morpho-pathology by seriated biopsies of healthy implanted hearts in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ recipients during 12-month follow-up from @DISEASE_605376 @DISEASE_OMIM:605376 @@@HTX@@@. Because @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduces @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@ectopic lipid accumulation@@@, we evaluated the effects of the drug in a nonrandomized subgroup. ", "citations": {"NLM": "Marfella R, Amarelli C, Cacciatore F, Balestrieri ML, Mansueto G, D'Onofrio N, Esposito S, Mattucci I, Salerno G, De Feo M, D'Amico M, Golino P, Maiello C, Paolisso G, Napoli C. Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients. J Am Coll Cardiol. 2020 Mar 24;75(11):1249-1262. PMID: 32192650", "BibTeX": "@article{32192650, title={Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.}, author={Marfella R and Amarelli C and Cacciatore F and Balestrieri ML and Mansueto G and D'Onofrio N and Esposito S and Mattucci I and Salerno G and De Feo M and D'Amico M and Golino P and Maiello C and Paolisso G and Napoli C}, journal={J Am Coll Cardiol}, volume={75}, number={11}, pages={1249-1262}}"}}, {"_id": "32697278", "pmid": 32697278, "pmcid": "PMC7537359", "title": "Influence of the use of atypical antipsychotics in metabolic syndrome", "journal": "Rev Esp Sanid Penit", "authors": ["Doménech-Matamoros P"], "date": "2020-05-01T00:00:00Z", "doi": "10.18176/resp.00014", "meta_date_publication": "2020 May-Aug", "meta_volume": "22", "meta_issue": "2", "meta_pages": "80-86", "score": 50232.79, "text_hl": "There is a relationship between the use of atypical antipsychotics and @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@, @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@lipid disorders@@@, @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ and high blood pressure. ", "citations": {"NLM": "Doménech-Matamoros P. Influence of the use of atypical antipsychotics in metabolic syndrome Rev Esp Sanid Penit. 2020 May-Aug;22(2):80-86. PMID: 32697278", "BibTeX": "@article{32697278, title={Influence of the use of atypical antipsychotics in metabolic syndrome}, author={Doménech-Matamoros P}, journal={Rev Esp Sanid Penit}, volume={22}, number={2}, pages={80-86}}"}}, {"_id": "23177353", "pmid": 23177353, "title": "Metformin: the hidden chronicles of a magic drug.", "journal": "Eur J Intern Med", "authors": ["Mahmood K", "Naeem M", "Rahimnajjad NA"], "date": "2013-01-01T00:00:00Z", "doi": "10.1016/j.ejim.2012.10.011", "meta_date_publication": "2013 Jan", "meta_volume": "24", "meta_issue": "1", "meta_pages": "20-6", "score": 50063.7, "text_hl": "Data has been conclusive that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ also has beneficial role in @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@lipid disorders@@@ as it improves the markers of @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@. ", "citations": {"NLM": "Mahmood K, Naeem M, Rahimnajjad NA. Metformin: the hidden chronicles of a magic drug. Eur J Intern Med. 2013 Jan;24(1):20-6. PMID: 23177353", "BibTeX": "@article{23177353, title={Metformin: the hidden chronicles of a magic drug.}, author={Mahmood K and Naeem M and Rahimnajjad NA}, journal={Eur J Intern Med}, volume={24}, number={1}, pages={20-6}}"}}, {"_id": "3552509", "pmid": 3552509, "title": "Role of metformin in treatment of diabetes mellitus.", "journal": "Diabetes Care", "authors": ["Vigneri R", "Goldfine ID"], "date": "1987-01-01T00:00:00Z", "doi": "10.2337/diacare.10.1.118", "meta_date_publication": "1987 Jan-Feb", "meta_volume": "10", "meta_issue": "1", "meta_pages": "118-22", "score": 50062.105, "text_hl": "In addition to its antidiabetic actions, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ causes @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ in @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ and may be useful in managing associated @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@lipid disorders@@@.", "citations": {"NLM": "Vigneri R, Goldfine ID. Role of metformin in treatment of diabetes mellitus. Diabetes Care. 1987 Jan-Feb;10(1):118-22. PMID: 3552509", "BibTeX": "@article{3552509, title={Role of metformin in treatment of diabetes mellitus.}, author={Vigneri R and Goldfine ID}, journal={Diabetes Care}, volume={10}, number={1}, pages={118-22}}"}}, {"_id": "26303871", "pmid": 26303871, "title": "Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice.", "journal": "Metabolism", "authors": ["Fu L", "Bruckbauer A", "Li F", "Cao Q", "Cui X", "Wu R", "Shi H", "Zemel MB", "Xue B"], "date": "2015-11-01T00:00:00Z", "doi": "10.1016/j.metabol.2015.07.006", "meta_date_publication": "2015 Nov", "meta_volume": "64", "meta_issue": "11", "meta_pages": "1426-34", "score": 50061.367, "text_hl": "Interaction between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Leucine @CHEMICAL_MESH:D007930 @@@leucine@@@ in reducing @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ and @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@hepatic lipid accumulation@@@ in diet-induced @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Fu L, Bruckbauer A, Li F, Cao Q, Cui X, Wu R, Shi H, Zemel MB, Xue B. Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice. Metabolism. 2015 Nov;64(11):1426-34. PMID: 26303871", "BibTeX": "@article{26303871, title={Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice.}, author={Fu L and Bruckbauer A and Li F and Cao Q and Cui X and Wu R and Shi H and Zemel MB and Xue B}, journal={Metabolism}, volume={64}, number={11}, pages={1426-34}}"}}, {"_id": "19758357", "pmid": 19758357, "title": "The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.", "journal": "Diabetes Obes Metab", "authors": ["Kazda C", "Gallwitz B", "Simó R", "Guzmán JR", "Kraus P", "Nicolay C", "Rose L", "Schernthaner G"], "date": "2009-12-01T00:00:00Z", "doi": "10.1111/j.1463-1326.2009.01091.x", "meta_date_publication": "2009 Dec", "meta_volume": "11", "meta_issue": "12", "meta_pages": "1131-7", "score": 50046.492, "text_hl": "CONCLUSION: @SPECIES_9606 @@@Patients@@@ included in the EUREXA study had early failure of @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ control with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and presented typical features of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@: @DISEASE_Overweight @DISEASE_MESH:D050177 @@@overweight@@@/@DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and high prevalence of @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@lipid abnormalities@@@ and @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@CVD@@@. ", "citations": {"NLM": "Kazda C, Gallwitz B, Simó R, Guzmán JR, Kraus P, Nicolay C, Rose L, Schernthaner G. The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics. Diabetes Obes Metab. 2009 Dec;11(12):1131-7. PMID: 19758357", "BibTeX": "@article{19758357, title={The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.}, author={Kazda C and Gallwitz B and Simó R and Guzmán JR and Kraus P and Nicolay C and Rose L and Schernthaner G}, journal={Diabetes Obes Metab}, volume={11}, number={12}, pages={1131-7}}"}}, {"_id": "11453331", "pmid": 11453331, "title": "Metformin and intervention in polycystic ovary syndrome. Endocrine Society of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group.", "journal": "Med J Aust", "authors": ["Norman RJ", "Kidson WJ", "Cuneo RC", "Zacharin MR"], "date": "2001-06-04T00:00:00Z", "doi": "10.5694/j.1326-5377.2001.tb143439.x", "meta_date_publication": "2001 Jun 4", "meta_volume": "174", "meta_issue": "11", "meta_pages": "580-3", "score": 50045.22, "text_hl": "The effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Pneumonia_Lipid</m> @DISEASE_MESH:D011017 @@@lipid abnormalities@@@, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ or premature @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@vascular disease@@@ are unknown, but the relative safety, moderate cost, and efficacy in reducing @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may prove to be of benefit in combating these components of the \"@DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic\" syndrome@@@ in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@. ", "citations": {"NLM": "Norman RJ, Kidson WJ, Cuneo RC, Zacharin MR. Metformin and intervention in polycystic ovary syndrome. Endocrine Society of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group. Med J Aust. 2001 Jun 4;174(11):580-3. PMID: 11453331", "BibTeX": "@article{11453331, title={Metformin and intervention in polycystic ovary syndrome. Endocrine Society of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group.}, author={Norman RJ and Kidson WJ and Cuneo RC and Zacharin MR}, journal={Med J Aust}, volume={174}, number={11}, pages={580-3}}"}}]}